
Delcath Systems DCTH
$ 11.54
-2.12%
Quarterly report 2026-Q1
added 05-07-2026
Delcath Systems Operating Expenses 2011-2026 | DCTH
Annual Operating Expenses Delcath Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 1988 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72.8 M | 43.4 M | 39.6 M | 35.9 M | 27.4 M | 22.3 M | 20.8 M | 29.5 M | 20.2 M | 17.9 M | 16.5 M | 20.1 M | 33.3 M | 54.2 M | 46.5 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 72.8 M | 16.5 M | 33.4 M |
Quarterly Operating Expenses Delcath Systems
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.9 M | 18.3 M | 18.2 M | 16.3 M | - | 10.8 M | 10.2 M | 12.5 M | - | 10.9 M | 8.34 M | 8.74 M | - | 8.84 M | 10.1 M | 8.68 M | - | 6.99 M | 6.78 M | 7 M | - | 5.26 M | 4.48 M | 5.29 M | - | 5.78 M | 4.37 M | 5.85 M | - | 6.38 M | 6.73 M | 8.06 M | 5.25 M | 5.14 M | 5.05 M | 4.74 M | 4.88 M | 5.05 M | 4.23 M | 3.72 M | - | 3.96 M | 3.95 M | 4.02 M | - | 5.22 M | 6.09 M | 5.28 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 22.9 M | 3.72 M | 7.8 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | ||
|
EDAP TMS S.A.
EDAP
|
47.1 M | - | - | $ 162 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
301 M | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
126 M | - | - | $ 10.2 M | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
15.3 M | $ 13.34 | -1.33 % | $ 378 M | ||
|
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
614 M | $ 8.44 | 1.81 % | $ 1.27 B | ||
|
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | ||
|
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.19 | 0.85 % | $ 20.2 M | ||
|
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
249 M | $ 1.63 | -6.86 % | $ 35.9 M | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.52 | 20.12 % | $ 32.4 M | ||
|
LivaNova PLC
LIVN
|
697 M | $ 79.48 | -0.28 % | $ 4.34 B | ||
|
OrthoPediatrics Corp.
KIDS
|
212 M | $ 18.53 | 2.09 % | $ 435 M | ||
|
Pulmonx Corporation
LUNG
|
121 M | $ 1.25 | -2.34 % | $ 50.9 M | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M | ||
|
LENSAR
LNSR
|
32.6 M | $ 6.18 | 8.04 % | $ 73.9 M | ||
|
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | ||
|
Orthofix Medical
OFIX
|
344 M | $ 9.41 | 2.28 % | $ 373 M | ||
|
Electromed
ELMD
|
40.3 M | $ 37.55 | -0.11 % | $ 317 M | ||
|
MiMedx Group
MDXG
|
277 M | $ 3.7 | 0.54 % | $ 547 M | ||
|
Butterfly Network
BFLY
|
132 M | $ 5.65 | 0.44 % | $ 1.4 B | ||
|
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | ||
|
Myomo
MYO
|
41.3 M | $ 1.46 | 8.15 % | $ 61.1 M | ||
|
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
887 M | $ 77.52 | 0.26 % | $ 10.5 B | ||
|
Profound Medical Corp.
PROF
|
52.6 M | $ 6.73 | 0.3 % | $ 203 M | ||
|
Insulet Corporation
PODD
|
531 M | $ 147.69 | -0.3 % | $ 10.4 B | ||
|
CONMED Corporation
CNMD
|
648 M | $ 34.57 | 1.2 % | $ 1.07 B | ||
|
Inspire Medical Systems
INSP
|
240 M | - | - | $ 1.22 B | ||
|
Integer Holdings Corporation
ITGR
|
279 M | - | - | $ 3.17 B | ||
|
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 88.58 | 2.67 % | $ 51.8 B | ||
|
TransMedics Group
TMDX
|
254 M | $ 75.82 | 0.45 % | $ 2.58 B |